ROI

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Zemcelpro® gains key reimbursement status, offering immediate hope and access for German patients with limited options and paving a new path for cell therapy.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

Backed by $7M, 19-year-old Mike Shperling's Skygen.AI is here to end the chatbot era with autonomous agents that work directly inside your software.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

A new $500M fund aims to profit from the U.S. housing shortage by banking on its scarcest resource: land. But can it deliver for investors and builders?

U Power (UCAR) presents its AI-driven energy grid strategy at a key conference, betting on a tech pivot to reignite investor interest after a steep decline.

With 15 'Best Bank' awards fueled by client feedback and record SBA lending, Huntington Bank demonstrates a winning formula for business banking success.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

The Estonian bank posts a 4% profit increase, balancing strong loan growth with a new five-year plan focused on digital expansion and investment services.

A landmark $30M ADB loan to GCash's lending arm aims to bridge a critical financing gap for small businesses and women entrepreneurs in the Philippines.

With a record 21st NMMA CSI Award, Tigé Boats isn't just winning trophies; it's redefining long-term owner loyalty in the competitive marine industry.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

Forward Industries' radical crypto pivot is a wild ride. Staking revenue is up 4x, but a market downturn triggered a staggering half-billion-dollar loss.

With a promising heart failure drug in trials, the biotech aims to woo investors at the Oppenheimer conference to fund its attack on age-related diseases.